Wright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Jefferies Reiterates Buy on Wright Medical Group (WMGI) Following 4Q
February 22, 2017 7:14 AM ESTJefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.
Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More
Needham & Company Maintains Hold Rating on Wright Medical Group (WMGI) Following Strong 4Q16 Results
February 22, 2017 6:26 AM ESTNeedham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.
Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More
Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
February 21, 2017 4:10 PM ESTWright Medical Group (NASDAQ: WMGI) reported Q4 EPS of ($0.29), which may note compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $193 million versus the consensus estimate of $183.56 million.
GUIDANCE:
Wright Medical Group sees FY2017 revenue of... More
